Global Multiple Myeloma Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 95
Published Date: 02 Jul 2021
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Multiple Myeloma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Multiple Myeloma Therapeutics size is estimated to be USD 41350 million in 2026 from USD 28060 million in 2020, with a change XX% between 2020 and 2021. The global Multiple Myeloma Therapeutics market size is expected to grow at a CAGR of 10.2% for the next five years.
Market segmentation
Multiple Myeloma Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Radiation
Stem Cell Transplant
Other Supportive Treatments
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Multiple Myeloma Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Multiple Myeloma Therapeutics, with revenue, gross margin and global market share of Multiple Myeloma Therapeutics from 2019 to 2021.
Chapter 3, the Multiple Myeloma Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Multiple Myeloma Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Multiple Myeloma Therapeutics research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Multiple Myeloma Therapeutics
1.2 Classification of Multiple Myeloma Therapeutics by Type
1.2.1 Overview: Global Multiple Myeloma Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Radiation
1.2.5 Stem Cell Transplant
1.2.6 Other Supportive Treatments
1.3 Global Multiple Myeloma Therapeutics Market by Application
1.3.1 Overview: Global Multiple Myeloma Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Multiple Myeloma Therapeutics Market Size & Forecast
1.5 Global Multiple Myeloma Therapeutics Market Size and Forecast by Region
1.5.1 Global Multiple Myeloma Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Multiple Myeloma Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Multiple Myeloma Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Multiple Myeloma Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Multiple Myeloma Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Multiple Myeloma Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Multiple Myeloma Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Multiple Myeloma Therapeutics Market Drivers
1.6.2 Multiple Myeloma Therapeutics Market Restraints
1.6.3 Multiple Myeloma Therapeutics Trends Analysis
2.1 Janssen Biotech, Inc.
2.1.1 Janssen Biotech, Inc. Details
2.1.2 Janssen Biotech, Inc. Major Business
2.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product and Solutions
2.1.4 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Janssen Biotech, Inc. Recent Developments and Future Plans
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Product and Solutions
2.2.4 Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Multiple Myeloma Therapeutics Product and Solutions
2.3.4 Novartis AG Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product and Solutions
2.4.4 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.5 Millennium Pharmaceuticals
2.5.1 Millennium Pharmaceuticals Details
2.5.2 Millennium Pharmaceuticals Major Business
2.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product and Solutions
2.5.4 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Millennium Pharmaceuticals Recent Developments and Future Plans
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business
2.6.3 Celgene Corporation Multiple Myeloma Therapeutics Product and Solutions
2.6.4 Celgene Corporation Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Celgene Corporation Recent Developments and Future Plans
2.7 Kesios Therapeutics Limited
2.7.1 Kesios Therapeutics Limited Details
2.7.2 Kesios Therapeutics Limited Major Business
2.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product and Solutions
2.7.4 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kesios Therapeutics Limited Recent Developments and Future Plans
2.8 Amgene, Inc.
2.8.1 Amgene, Inc. Details
2.8.2 Amgene, Inc. Major Business
2.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Product and Solutions
2.8.4 Amgene, Inc. Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Amgene, Inc. Recent Developments and Future Plans
2.9 Genzyme Corporation
2.9.1 Genzyme Corporation Details
2.9.2 Genzyme Corporation Major Business
2.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Product and Solutions
2.9.4 Genzyme Corporation Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genzyme Corporation Recent Developments and Future Plans
2.10 Juno Therapeutics
2.10.1 Juno Therapeutics Details
2.10.2 Juno Therapeutics Major Business
2.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Product and Solutions
2.10.4 Juno Therapeutics Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Juno Therapeutics Recent Developments and Future Plans
3.1 Global Multiple Myeloma Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Multiple Myeloma Therapeutics Players Market Share
3.2.2 Top 10 Multiple Myeloma Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Multiple Myeloma Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Multiple Myeloma Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Multiple Myeloma Therapeutics Market Forecast by Type (2021-2026)
5.1 Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Multiple Myeloma Therapeutics Market Forecast by Application (2021-2026)
6.1 North America Multiple Myeloma Therapeutics Revenue by Type (2016-2026)
6.2 North America Multiple Myeloma Therapeutics Revenue by Application (2016-2026)
6.3 North America Multiple Myeloma Therapeutics Market Size by Country
6.3.1 North America Multiple Myeloma Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
7.1 Europe Multiple Myeloma Therapeutics Revenue by Type (2016-2026)
7.2 Europe Multiple Myeloma Therapeutics Revenue by Application (2016-2026)
7.3 Europe Multiple Myeloma Therapeutics Market Size by Country
7.3.1 Europe Multiple Myeloma Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Multiple Myeloma Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Multiple Myeloma Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region
8.3.1 Asia-Pacific Multiple Myeloma Therapeutics Revenue by Region (2016-2026)
8.3.2 China Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
9.1 South America Multiple Myeloma Therapeutics Revenue by Type (2016-2026)
9.2 South America Multiple Myeloma Therapeutics Revenue by Application (2016-2026)
9.3 South America Multiple Myeloma Therapeutics Market Size by Country
9.3.1 South America Multiple Myeloma Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Multiple Myeloma Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Multiple Myeloma Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country
10.3.1 Middle East & Africa Multiple Myeloma Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Multiple Myeloma Therapeutics Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Multiple Myeloma Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Multiple Myeloma Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Multiple Myeloma Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Multiple Myeloma Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Multiple Myeloma Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Janssen Biotech, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Janssen Biotech, Inc. Major Business
Table 8. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product and Solutions
Table 9. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 11. Bristol-Myers Squibb Major Business
Table 12. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product and Solutions
Table 13. Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 15. Novartis AG Major Business
Table 16. Novartis AG Multiple Myeloma Therapeutics Product and Solutions
Table 17. Novartis AG Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Company Major Business
Table 20. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product and Solutions
Table 21. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Millennium Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Millennium Pharmaceuticals Major Business
Table 24. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product and Solutions
Table 25. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Celgene Corporation Major Business
Table 28. Celgene Corporation Multiple Myeloma Therapeutics Product and Solutions
Table 29. Celgene Corporation Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kesios Therapeutics Limited Corporate Information, Head Office, and Major Competitors
Table 31. Kesios Therapeutics Limited Major Business
Table 32. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product and Solutions
Table 33. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Amgene, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Amgene, Inc. Major Business
Table 36. Amgene, Inc. Multiple Myeloma Therapeutics Product and Solutions
Table 37. Amgene, Inc. Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genzyme Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Genzyme Corporation Major Business
Table 40. Genzyme Corporation Multiple Myeloma Therapeutics Product and Solutions
Table 41. Genzyme Corporation Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Juno Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Juno Therapeutics Major Business
Table 44. Juno Therapeutics Multiple Myeloma Therapeutics Product and Solutions
Table 45. Juno Therapeutics Multiple Myeloma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Multiple Myeloma Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Multiple Myeloma Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Multiple Myeloma Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Multiple Myeloma Therapeutics Players Head Office, Products and Services Provided
Table 50. Multiple Myeloma Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Multiple Myeloma Therapeutics New Entrants and Expansion Plans
Table 52. Global Multiple Myeloma Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Multiple Myeloma Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Multiple Myeloma Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Multiple Myeloma Therapeutics Revenue by Application (2016-2021)
Table 56. Global Multiple Myeloma Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Multiple Myeloma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Multiple Myeloma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Multiple Myeloma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Multiple Myeloma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Multiple Myeloma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Multiple Myeloma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Multiple Myeloma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Multiple Myeloma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Multiple Myeloma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Multiple Myeloma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Multiple Myeloma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Multiple Myeloma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Multiple Myeloma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Multiple Myeloma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Multiple Myeloma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Multiple Myeloma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Multiple Myeloma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Multiple Myeloma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Multiple Myeloma Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Multiple Myeloma Therapeutics Picture
Figure 2. Global Multiple Myeloma Therapeutics Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Radiation
Figure 5. Stem Cell Transplant
Figure 6. Other Supportive Treatments
Figure 7. Multiple Myeloma Therapeutics Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Multiple Myeloma Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Multiple Myeloma Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Multiple Myeloma Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Multiple Myeloma Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Multiple Myeloma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Multiple Myeloma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Multiple Myeloma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Multiple Myeloma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Multiple Myeloma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Multiple Myeloma Therapeutics Market Drivers
Figure 21. Multiple Myeloma Therapeutics Market Restraints
Figure 22. Multiple Myeloma Therapeutics Market Trends
Figure 23. Janssen Biotech, Inc. Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Novartis AG Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 27. Millennium Pharmaceuticals Recent Developments and Future Plans
Figure 28. Celgene Corporation Recent Developments and Future Plans
Figure 29. Kesios Therapeutics Limited Recent Developments and Future Plans
Figure 30. Amgene, Inc. Recent Developments and Future Plans
Figure 31. Genzyme Corporation Recent Developments and Future Plans
Figure 32. Juno Therapeutics Recent Developments and Future Plans
Figure 33. Global Multiple Myeloma Therapeutics Revenue Share by Players in 2020
Figure 34. Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Multiple Myeloma Therapeutics Revenue Market Share in 2020
Figure 36. Global Top 10 Players Multiple Myeloma Therapeutics Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Multiple Myeloma Therapeutics Revenue Share by Type in 2020
Figure 39. Global Multiple Myeloma Therapeutics Market Share Forecast by Type (2021-2026)
Figure 40. Global Multiple Myeloma Therapeutics Revenue Share by Application in 2020
Figure 41. Global Multiple Myeloma Therapeutics Market Share Forecast by Application (2021-2026)
Figure 42. North America Multiple Myeloma Therapeutics Sales Market Share by Type (2016-2026)
Figure 43. North America Multiple Myeloma Therapeutics Sales Market Share by Application (2016-2026)
Figure 44. North America Multiple Myeloma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 45. United States Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Multiple Myeloma Therapeutics Sales Market Share by Type (2016-2026)
Figure 49. Europe Multiple Myeloma Therapeutics Sales Market Share by Application (2016-2026)
Figure 50. Europe Multiple Myeloma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 51. Germany Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Multiple Myeloma Therapeutics Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Multiple Myeloma Therapeutics Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Multiple Myeloma Therapeutics Revenue Market Share by Region (2016-2026)
Figure 59. China Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Multiple Myeloma Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. South America Multiple Myeloma Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. South America Multiple Myeloma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Multiple Myeloma Therapeutics Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Multiple Myeloma Therapeutics Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Janssen Biotech, Inc. Bristol-Myers Squibb Novartis AG Bristol-Myers Squibb Company Millennium Pharmaceuticals Celgene Corporation Kesios Therapeutics Limited Amgene, Inc. Genzyme Corporation Juno Therapeutics
Related Reports
08 Jan 2022
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
